Morphic Therapeutic
MORF
#4137
Rank
NZ$4.80 B
Marketcap
NZ$95.70
Share price
0.00%
Change (1 day)
146.09%
Change (1 year)

Earnings for Morphic Therapeutic (MORF)

Earnings in 2024 (TTM): -NZ$0.35 Billion

According to Morphic Therapeutic's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -NZ$0.31 Billion a decrease over its 2022 earnings that were of -NZ$0.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Morphic Therapeutic from 2018 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$0.35 Billion16.41%
2023 -NZ$0.31 Billion181.86%
2022 -NZ$0.11 Billion-33.83%
2021 -NZ$0.17 Billion103.07%
2020 -NZ$79.23 Million0.41%
2019 -NZ$78.91 Million90.79%
2018 -NZ$41.36 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-NZ$0.27 Billion-25.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-NZ$30.49 Million-91.48%๐Ÿ‡บ๐Ÿ‡ธ USA